BridgeMD
New treatment option for Nutrition
Official title Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic Syndrome
ClinicalTrials.gov ID: NCT06978504
What this study is testing
- What it's testing
- Metabolic syndrome is a multifactorial inflammatory condition that is very prevalent in overweight women with type 2 diabetes. However, there seems to be great benefit in changing lifestyle and dietary patterns in the treatment of this condition.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60, women only. Healthy volunteers may be eligible.
You may be able to join if
- The study population will consist of menopausal women aged between 40 to 60 years old
- Obese (BMI \> 30) with a diagnosis of MS. The are the presence of at least 3 of the 5 criteria\ for MS, which include:
- Abnormal waist circumference values (≥89 cm in women)
- SBP ≥120 mm Hg and DBP ≥80 mm Hg) or diagnosis of hypertension
- Fasting blood glucose equal to or greater than 100 mg/dL or diagnosis of DM2
You likely can't join if
- Patients with a BMI \<25 kg/m2 The following chronic diseases will not be eligible:
- Active cancer
- Active tuberculosis
- Psychiatric illnesses
- Multiple sclerosis
- Severe nephropathy
See the full eligibility criteria
- The study population will consist of menopausal women aged between 40 to 60 years old
- Obese (BMI \> 30) with a diagnosis of MS. The are the presence of at least 3 of the 5 criteria\ for MS, which include:
- Abnormal waist circumference values (≥89 cm in women)
- SBP ≥120 mm Hg and DBP ≥80 mm Hg) or diagnosis of hypertension
- Fasting blood glucose equal to or greater than 100 mg/dL or diagnosis of DM2
- HDL-c less than 50 mg/dL in women
- Triglycerides ≥150 mg/dL.
- Patients with a BMI \<25 kg/m2 The following chronic diseases will not be eligible:
- Active cancer
- Active tuberculosis
- Psychiatric illnesses
- Multiple sclerosis
- Severe nephropathy
- Advanced stages of Paget's disease. These chronic conditions could interfere with the results of this study, especially adherence to diet and weight loss. Patients who do not complete all stages of the study, who are...
The study team makes the final eligibility decision.
Where it's taking place
- Rio de Janeiro, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 40 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rio de Janeiro, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.